← Browse by Condition
Medical Condition

unresectable skin squamous cell carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05269381 Phase 1, Phase 2
Recruiting

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Enrollment
132 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →